{
    "Trade/Device Name(s)": [
        "VITEK 2 AST-Gram Negative Piperacillin / Tazobactam",
        "VITEK 2 Gram Negative Piperacillin/Tazobactam",
        "VITEK 2 AST-GN Piperacillin/Tazobactam"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K211630",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113200"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "LTW",
        "LTT"
    ],
    "Summary Letter Date": "May 25, 2021",
    "Summary Letter Received Date": "May 27, 2021",
    "Submission Date": "May 25, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Acinetobacter baumanii",
        "Escherichia coli",
        "Klebsiella pneumoniae",
        "Pseudomonas aeruginosa",
        "Citrobacter koseri",
        "Morganella morganii",
        "Proteus mirabilis",
        "Proteus vulgaris",
        "Providencia rettgeri",
        "Providencia stuartii",
        "Salmonella enterica"
    ],
    "Specimen Type(s)": [
        "Bacterial isolate"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2",
        "VITEK 2 COMPACT"
    ],
    "Method(s)/Technology(ies)": [
        "Minimum inhibitory concentration (MIC) microdilution",
        "Automated susceptibility testing"
    ],
    "Methodologies": [
        "Broth microdilution",
        "Automated incubation and growth monitoring"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "System",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 Gram Negative Piperacillin/Tazobactam antimicrobial susceptibility test on VITEK 2 and VITEK 2 COMPACT systems with updated breakpoints for Pseudomonas aeruginosa",
    "Indications for Use Summary": "Intended for antimicrobial susceptibility testing of selected Gram-negative organisms using the VITEK 2 and VITEK 2 COMPACT systems as a laboratory aid for determining in vitro susceptibility to Piperacillin/Tazobactam",
    "fda_folder": "Microbiology"
}